1. Home
  2. NSPR vs FONR Comparison

NSPR vs FONR Comparison

Compare NSPR & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • FONR
  • Stock Information
  • Founded
  • NSPR 2005
  • FONR 1978
  • Country
  • NSPR United States
  • FONR United States
  • Employees
  • NSPR N/A
  • FONR N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NSPR Health Care
  • FONR Health Care
  • Exchange
  • NSPR Nasdaq
  • FONR Nasdaq
  • Market Cap
  • NSPR 99.7M
  • FONR 100.6M
  • IPO Year
  • NSPR N/A
  • FONR 1987
  • Fundamental
  • Price
  • NSPR $2.42
  • FONR N/A
  • Analyst Decision
  • NSPR Strong Buy
  • FONR
  • Analyst Count
  • NSPR 2
  • FONR 0
  • Target Price
  • NSPR $4.50
  • FONR N/A
  • AVG Volume (30 Days)
  • NSPR 119.2K
  • FONR 15.4K
  • Earning Date
  • NSPR 11-11-2025
  • FONR 11-11-2025
  • Dividend Yield
  • NSPR N/A
  • FONR N/A
  • EPS Growth
  • NSPR N/A
  • FONR N/A
  • EPS
  • NSPR N/A
  • FONR 1.26
  • Revenue
  • NSPR $7,066,000.00
  • FONR $104,351,318.00
  • Revenue This Year
  • NSPR $7.48
  • FONR N/A
  • Revenue Next Year
  • NSPR $104.39
  • FONR N/A
  • P/E Ratio
  • NSPR N/A
  • FONR $12.75
  • Revenue Growth
  • NSPR 7.60
  • FONR 1.43
  • 52 Week Low
  • NSPR $1.99
  • FONR $12.00
  • 52 Week High
  • NSPR $3.80
  • FONR $17.62
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 49.42
  • FONR 53.28
  • Support Level
  • NSPR $2.38
  • FONR $15.08
  • Resistance Level
  • NSPR $2.57
  • FONR $16.25
  • Average True Range (ATR)
  • NSPR 0.07
  • FONR 0.32
  • MACD
  • NSPR 0.01
  • FONR 0.06
  • Stochastic Oscillator
  • NSPR 31.97
  • FONR 48.91

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Share on Social Networks: